Entrada Therapeutics (TRDA)

Entrada Therapeutics Inc is a clinical-stage biopharmaceutical company. It aims to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient intracellular delivery into a variety of organs and tissues, resulting in an improved therapeutic index and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. Its oligonucleotide programs are in development for the potential treatment of people living with Duchenne, which are exon 44, 45, 50, and 51 skipping amenable. It has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.

的Entrada Therapeutics, Inc. Common Stock（TRDA）股票的价格今天是$11.69，自市场开启。该公司市值为$4.47亿，日交易量为$12.84万股。对于关注价格走势的投资者来说，Entrada Therapeutics, Inc. Common Stock股票今日的波动区间在$11.25和$11.79之间。前一交易日收盘价为 $11.96。

您准备好开始了吗？按照以下步骤操作，或阅读我们关于在Kraken上从10美元起购买Entrada Therapeutics股票的指南。